← Back to Clinical Trials
Recruiting NCT07276152

Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology

Trial Parameters

Condition Sonic Augmentation Technology
Sponsor University Hospital, Basel, Switzerland
Study Type INTERVENTIONAL
Phase N/A
Enrollment 22
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-01-09
Completion 2026-08
Interventions
sonic augmentation technology

Brief Summary

The investigator aim to investigate wheather music modified by sonic augmentation technology can produce increasing oxytocin levels with minimal to no side effects in a highly standardized setting

Eligibility Criteria

Part 1: Inclusion Criteria: * Adult healthy controls * No medication, except hormonal contraception Exclusion Criteria: * Participation in a trial with investigational drugs within 30 days * Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months * Consumption of alcoholic beverages \>15 drinks/week * Tobacco smoking \>10 cigarettes/day * Current or previous major psychiatric disorder (e.g., major depression, schizophrenia spectrum disorder) * Psychotic disorder in first-degree relatives * Pregnancy and breastfeeding Part 2: Inclusion Criteria: * Confirmed diagnosis of AVP-Deficiency * Age ≥ 18 years Exclusion Criteria: * Participation in a trial with investigational drugs within 30 days * Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months * Consumption of alcoholic beverages \>15 drinks/week * Tobacco smoking \>10 cigarettes/day * Current or previous major p

Related Trials